D.A. Davidson & Co’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.6K Hold
21,779
﹤0.01% 1572
2026
Q1
$52.7K Hold
21,779
﹤0.01% 1547
2025
Q4
$95K Hold
21,779
﹤0.01% 1492
2025
Q3
$91.5K Hold
21,779
﹤0.01% 1488
2025
Q2
$62.5K Hold
21,779
﹤0.01% 1418
2025
Q1
$58.8K Hold
21,779
﹤0.01% 1381
2024
Q4
$51.4K Buy
+21,779
New +$57.9K ﹤0.01% 1393
2023
Q4
Sell
-9,666
Closed -$237K 1394
2023
Q3
$237K Buy
+9,666
New +$245K ﹤0.01% 1164

Other funds holding GNLX

D.A. Davidson & Co's GNLX Position: Q2 2026 in Review

D.A. Davidson & Co held its Genelux (GNLX) position steady in Q2 2026 at 21,779 shares worth $65.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1572.

D.A. Davidson & Co first reported a position in GNLX in Q3 2023 and has held it in 8 quarters since. The position peaked at $237K in Q3 2023. 22 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • D.A. Davidson & Co held 21,779 shares of Genelux worth $65.6K as of Q2 2026.
  • D.A. Davidson & Co left its Genelux share count unchanged in Q2 2026.
  • Genelux made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #1572 holding.
  • D.A. Davidson & Co first reported a position in Genelux in Q3 2023 and has held it in 8 quarters since.
  • D.A. Davidson & Co's Genelux position peaked at $237K in Q3 2023.
  • 22 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.